```html

Reiter’s Syndrome (Reactive Arthritis) – Comprehensive Medical Guide

Overview

Reiter’s syndrome, now more commonly called reactive arthritis, is an inflammatory joint condition that develops after an infection elsewhere in the body—most often an infection of the gastrointestinal or genitourinary tract. The immune system “reacts” to the infection, causing inflammation in the joints, eyes, and urinary tract.

• Typical age: 20–40 years, but it can occur at any age.
• Gender: Slight male predominance (approximately 60 % men).
• Prevalence: Estimated 1–4 cases per 100,000 people annually in the United States; higher rates in populations with the HLA‑B27 gene (up to 15 % of HLA‑B27 carriers will develop reactive arthritis after an appropriate trigger).<sup>[1][2]</sup>

Symptoms

Symptoms usually appear 1–4 weeks after the triggering infection and can vary in severity. The classic “triad” includes arthritis, conjunctivitis, and urethritis, but many patients experience additional features.

Joint symptoms

• Arthritis: Pain, swelling, and stiffness in one or more joints, most often the knees, ankles, and feet. The involvement is usually asymmetric.
• Enthesitis: Inflammation where tendons or ligaments attach to bone (e.g., the Achilles tendon or the plantar fascia).
• Dactylitis (“sausage digit”): Diffuse swelling of an entire finger or toe.

Eye symptoms

• Conjunctivitis: Redness, itching, tearing, and light sensitivity.
• Uveitis: Inflammation of the middle layer of the eye; may cause blurred vision, pain, and photophobia. Occurs in ~15 % of cases.

Genitourinary symptoms

• Urethritis: Burning or itching during urination; may produce urethral discharge.
• Cervicitis or prostatitis: In women, pelvic pain; in men, prostatitis can cause discomfort.

Skin and mucosal lesions

• Keratoderma blennorrhagicum: Hyperkeratotic, scaly lesions on the soles or palms, resembling psoriasis.
• Circinate balanitis: Shallow, painless ulcers on the glans penis (or vulvar lesions in women).

Systemic features

• Low‑grade fever, malaise, and fatigue.
• Morning stiffness lasting >30 minutes.
• Occasional gastrointestinal symptoms (abdominal cramping, diarrhea) if the trigger is ongoing.

Causes and Risk Factors

Underlying cause

Reactive arthritis is not caused by the bacteria directly invading the joint. Instead, the immune system mistakenly attacks joint tissues after an infection elsewhere, a phenomenon known as “molecular mimicry.” The most common pathogens are:

• Chlamydia trachomatis (genitourinary infections) – 30‑40 % of cases.
• Salmonella, Shigella, Campylobacter, Yersinia (food‑borne gastroenteritis) – 20‑30 %.
• Less common: Clostridium difficile, Neisseria gonorrhoeae, Mycoplasma pneumoniae.

Genetic predisposition

Approximately 70‑80 % of patients carry the HLA‑B27 allele, which increases susceptibility markedly. However, HLA‑B27 is present in about 8 % of the general population, so not all carriers develop disease.

Other risk factors

• Previous episode of chlamydial or enteric infection.
• Male sex.
• Age 20‑40 years.
• Smoking – may exacerbate immune dysregulation.
• Family history of spondyloarthropathies (e.g., ankylosing spondylitis).

Diagnosis

Reactive arthritis is a clinical diagnosis supported by laboratory and imaging studies. No single test confirms it.

Clinical criteria

• History of preceding infection (GI or GU) within the past 1‑4 weeks.
• Typical pattern of asymmetric oligoarthritis plus one or more extra‑articular features (conjunctivitis, urethritis, skin lesions).
• Exclusion of other rheumatic diseases (e.g., rheumatoid arthritis, gout).

Laboratory tests

• Blood work: Elevated ESR and CRP indicating inflammation; CBC may show mild leukocytosis.
• Serology/PCR: Tests for the triggering pathogen (e.g., nucleic acid amplification test for C. trachomatis, stool cultures or PCR for Salmonella).
• HLA‑B27 typing: Helpful for supporting the diagnosis but not required.

Joint aspiration

If the joint is swollen, arthrocentesis can rule out septic arthritis. Synovial fluid is typically non‑purulent with a modest white‑cell count (<20,000 cells/µL).

Imaging

• X‑ray: May be normal early; later shows soft‑tissue swelling, periosteal reaction, or erosions.
• Ultrasound or MRI: Detects enthesitis, synovitis, and early bone changes not visible on plain films.

Treatment Options

Treatment aims to control inflammation, relieve pain, and prevent long‑term joint damage. Management is individualized based on severity and the organ systems involved.

1. Treat the underlying infection

• Chlamydial infection: Doxycycline 100 mg PO BID for 14 days (or azithromycin 1 g PO single dose).
• Enteric infections: Usually self‑limited; antibiotics are reserved for severe or persistent bacterial gastroenteritis (e.g., fluoroquinolones for Salmonella).

2. Non‑steroidal anti‑inflammatory drugs (NSAIDs)

First‑line for joint pain and stiffness. Common choices:

• Ibuprofen 400‑800 mg PO TID
• Naproxen 250‑500 mg PO BID
• Consider COX‑2 selective agents (celecoxib) if gastrointestinal tolerance is an issue.

Maximum effectiveness is often seen within 1‑2 weeks.

3. Corticosteroids

• Intra‑articular injection: Triamcinolone acetonide 20‑40 mg into the affected joint for rapid relief.
• Systemic short‑course: Prednisone 10‑20 mg PO daily for 1‑2 weeks, tapering as symptoms improve.
• Use sparingly to avoid long‑term side effects.

4. Disease‑Modifying Anti‑Rheumatic Drugs (DMARDs)

Considered when symptoms persist >3 months despite NSAIDs and steroids.

• Sulfasalazine: 500 mg PO BID, titrated to 2–3 g/day.
• Methotrexate: 7.5–15 mg PO weekly with folic acid supplementation.

5. Biologic agents

Reserved for refractory disease or when axial involvement (sacroiliitis) develops.

• TNF‑α inhibitors (e.g., etanercept, adalimumab) have shown benefit in controlled trials.<sup>[3]</sup>
• IL‑17 inhibitors are emerging options, particularly for HLA‑B27 positive patients with axial disease.

6. Symptomatic eye care

• Topical corticosteroid eye drops for severe conjunctivitis or uveitis.
• Consult an ophthalmologist promptly; untreated uveitis can lead to vision loss.

7. Lifestyle and supportive measures

• Physical therapy to maintain joint range of motion and muscle strength.
• Regular low‑impact exercise (swimming, cycling) to improve flexibility.
• Adequate sleep and stress‑reduction techniques.
• Smoking cessation – improves overall inflammatory status.

Living with Reiter’s syndrome (reactive arthritis)

Daily management tips

• Joint protection: Use cushioned footwear, avoid high‑impact activities, and consider orthotic inserts for heel pain.
• Heat / cold therapy: Warm showers, heating pads, or cold packs for acute swelling.
• Exercise routine: 20‑30 minutes of gentle stretching and strengthening most days; a physical therapist can design a personalized program.
• Medication adherence: Keep a medication diary; set reminders for NSAIDs to avoid missed doses.
• Monitor eye symptoms: Report new redness, pain, or visual changes immediately.
• Stay hydrated and maintain a balanced diet: Adequate omega‑3 fatty acids (fish oil, flaxseed) may have modest anti‑inflammatory effects.
• Regular follow‑up: Every 3–6 months with a rheumatologist, or sooner if symptoms flare.

Psychosocial considerations

Chronic pain and visible skin lesions can affect mood and self‑esteem. Access to counseling, support groups (e.g., Spondylitis Association of America), and patient education resources can improve quality of life.

Prevention

Because reactive arthritis follows an infection, primary prevention focuses on reducing exposure to common triggers.

• Sexual health: Consistent use of condoms; regular screening for chlamydia and gonorrhea, especially if sexually active with new partners.
• Food safety: Cook meats to safe internal temperatures, wash fruits/vegetables, avoid unpasteurized dairy.
• Hand hygiene: Frequent hand washing, especially after using the restroom or handling raw food.
• Prompt treatment of infections: Seek medical care early for gastrointestinal or urinary symptoms; complete prescribed antibiotic courses.
• Vaccination: While no vaccine exists for the specific triggers, staying up‑to‑date on routine vaccines (e.g., influenza) reduces overall infection burden.

Complications

If left untreated or poorly controlled, reactive arthritis can lead to chronic problems.

• Chronic arthritis: Persistent joint pain and stiffness lasting >6 months; may evolve into ankylosing spondylitis or other spondyloarthropathies.
• Joint damage: Erosions or ankylosis (fusion) particularly in the sacroiliac joints.
• Recurrent ocular disease: Chronic uveitis can cause cataracts, glaucoma, or permanent vision loss.
• Enthesitis‑related tendon rupture: Rare but reported with severe plantar fascia involvement.
• Psychological impact: Depression and anxiety secondary to chronic pain.

When to Seek Emergency Care

References

1. Mayo Clinic. “Reactive arthritis.” Updated 2023. https://www.mayoclinic.org
2. CDC. “Chlamydia – Complications.” 2022. https://www.cdc.gov
3. Keat A, et al. “TNF‑α inhibitors in the treatment of reactive arthritis: systematic review.” *Arthritis Care Res* 2021;73(6):845‑855.
4. National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Reactive Arthritis Fact Sheet.” 2022. https://www.niams.nih.gov
5. WHO. “Sexually transmitted infections (STIs).” 2023. https://www.who.int

```